LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
XELB
Xcel Brands, Inc.
There isn't enough reported data to score XELB yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XELB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
XELB's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
XELB PE Valuation
XELB has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XELB Forward outlook
There aren't enough analyst estimates for XELB to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus XELB down 236%.
XELB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$14.01 | -$3.71 |
| Q2 2025 | -$15.89 | -$6.89 |
| Q1 2025 | -$14.13 | -$3.23 |
| Q4 2024 | -$16.05 | -$5.35 |
| Q3 2024 | -$10.30 | -$0.10 |
| Q2 2024 | -$9.00 | +$0.70 |
| Q1 2024 | -$10.90 | -$7.80 |
| Q4 2023 | -$10.70 | -$8.70 |
XELB lost $14.01 per share over the past year, a bigger loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over XELB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
XELB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.1M | -15% |
| Q1 2026 | $1.1M | -14% |
| Q4 2025 | $1.2M | -3.4% |
| Q3 2025 | $1.1M | -42% |
| Q2 2025 | $1.3M | -55% |
| Q1 2025 | $1.3M | -39% |
| Q4 2024 | $1.2M | -47% |
| Q3 2024 | $1.9M | -27% |
XELB's revenue has slid since its 2019 peak: $1M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -141% | -16 points |
| Q1 2026 | -165% | -0.5 points |
| Q4 2025 | -167% | +366 points |
| Q3 2025 | -666% | -191 points |
| Q2 2025 | -125% | -136 points |
| Q1 2025 | -164% | +120 points |
| Q4 2024 | -533% | -287 points |
| Q3 2024 | -475% | -270 points |
XELB has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
XELB has the stronger cash trend. Its trailing FCF is down 16% versus its history, compared with LCID at down 75%.
XELB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.8M | -$418K |
| Q3 2025 | -$1.4M | -$966K |
| Q4 2024 | -$1.4M | +$2.3M |
| Q3 2024 | -$432K | +$913K |
| Q4 2023 | -$3.7M | -$571K |
| Q3 2023 | -$1.3M | +$1.1M |
| Q2 2023 | $1.4M | +$9.3M |
| Q1 2023 | -$3M | -$2.1M |
XELB has burned cash in most quarters: −$7M over the past year, against −$7M the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over XELB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
XELB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +256K shares |
| 1 year | +159% | +3.8M shares |
| 3 years | +214% | +4.2M shares |
| 5 years | +220% | +4.2M shares |
| Available history | +225% | +4.3M shares |
XELB has 6M diluted shares, up 159% from a year ago, despite $190,000 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $56,000 |
| Q1 2026 | $46,000 |
| Q4 2025 | $82,000 |
| Q3 2025 | $6,000 |
| Q2 2025 | $58,000 |
| Q1 2025 | $58,000 |
| Q4 2022 | — |
| Q3 2022 | — |
XELB spent $190,000 buying back its own shares over the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XELB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -0.8x | Net Cash |
| Q4 2019 | 11.0x | High |
| Q3 2019 | 1.9x | Healthy |
XELB has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
XELB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.2 | Oversold |
| Stochastic | 11.5 | Oversold |
XELB's weekly RSI is 27 (oversold) and its Stochastic is 12 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
XELB PE vs Consumer Cyclical Sector
| Metric | XELB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
XELB has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
XELB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.50 | 30% below |
| 20 week MA | $0.88 | 60% below |
| 50 week MA | $1.36 | 74% below |
| 100 week MA | $1.87 | 81% below |
| 200 week MA | $5.57 | 94% below |
XELB is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over XELB on returns for 2026, with the stronger performance.
XELB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $11.4 | -29% |
| 2021 | $11.4 | $12.0 | +5.3% |
| 2022 | $12.0 | $7.40 | -38% |
| 2023 | $7.40 | $12.9 | +74% |
| 2024 | $12.9 | $4.85 | -62% |
| 2025 | $4.85 | $1.37 | -72% |
| 2026 YTD | $1.37 | $0.35 | -74% |
XELB has finished lower in four of the last six years. It's down 74% so far in 2026.